The downside is that the cash - back
rate on other purchases outside the rotating categories is not very generous.
Some programs may offer a larger cash back rate in specific set categories, such as gas or restaurant purchases, while offering a smaller unlimited
rate on other purchases.
Earns high - rate rewards (some as much as 6 %) on spending categories that change periodically, and a lower
rate on all other purchases (usually 1 %)
But the rewards
rate on other purchases may not be very generous.
For example, there are credit cards that consistently offer higher cash back on grocery and gas purchases while offering a lower cash back
rate on all other purchases.
Furthermore, the card has a subpar 1 % rewards
rate on all other purchases.
The downside is that the cash - back
rate on other purchases outside the rotating categories is not very generous.
The rewards
rate on all other purchases is a robust 2x miles per dollar while the sign - up bonus of 50,000 miles is a healthy dollop to jump start your earnings.
They have a great rewards rate when shopping with the co-branded airline, and a subpar
rate on all other purchases.
But the rewards
rate on other purchases may not be very generous.
But the cash - back
rate on other purchases outside the rotating categories may not be very generous.
But the cash - back
rate on other purchases outside the rotating categories may not be very generous.
The downside is that the cash - back
rate on other purchases outside the rotating categories is not very generous.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses
on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build
rates of certain aircraft; 6) the effect
on aircraft demand and build
rates of changing customer preferences for business aircraft, including the effect of global economic conditions
on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange
rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or
other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our
other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and
other customers, and the risk of nonpayment by such customers; 13) any adverse impact
on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact
on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or
other security attacks, information technology failures, or
other disruptions; 16) returns
on pension plan assets and the impact of future discount
rate changes
on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the
purchase price for our announced acquisition of Asco
on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and
other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted
on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit
ratings; 22) our dependence
on our suppliers, as well as the cost and availability of raw materials and
purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and
other governments
on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest
on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest
rates increase substantially; 27) the effectiveness of any interest
rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and
other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and
other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange
rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among
other things.
However, cross-border
purchases can take buyers out of their comfort zone, forcing them to pay in a foreign currency at unclear exchange
rates, unable to use their preferred payment methods and unclear
on questions of duties, taxes, customs, shipping, and
other hidden costs.
Estimate the location's
purchasing power, based
on its per - capita income, its median income level, the unemployment
rate, population and
other demographic factors.
Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, and capital markets conditions and
other factors beyond the Company's control, including natural and
other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) the Company's credit
ratings and its cost of capital; (3) competitive conditions and customer preferences; (4) foreign currency exchange
rates and fluctuations in those
rates; (5) the timing and market acceptance of new product offerings; (6) the availability and cost of
purchased components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused by natural and
other disasters and
other events); (7) the impact of acquisitions, strategic alliances, divestitures, and
other unusual events resulting from portfolio management actions and
other evolving business strategies, and possible organizational restructuring; (8) generating fewer productivity improvements than estimated; (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and
other disruptions to the Company's information technology infrastructure; (10) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; and (11) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report
on Form 10 - K for the year ended Dec. 31, 2017, and any subsequent quarterly reports
on Form 10 - Q (the «Reports»).
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and
other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required
on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP
purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or
other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over
other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or
other market conditions; fluctuations in the foreign exchange
rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact
on Gilead's future revenues and pre-tax earnings; and
other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
0.0 % intro APR
on purchases and balance transfers for 15 months, then a variable
rate, currently 12.74 %, 16.74 % or 20.74 %, based
on your creditworthiness and
other factors as determined at the time of account opening.
This bonus offer is comparable to the
other flat
rate rewards cards that earn 1.5 %
on every credit card
purchase.
Ethereum
on the
other hand has no maximum supply, and is capped at an annual
rate of 18 million ether — meaning that the
purchasing power of a deflationary currency (bitcoin) is expected to rise over time, whereas the value of an inflationary currency (ether) will drop.
Economic pundits arguing that the Canadian dollar is overvalued often base their view
on the theory of
purchasing power parity (PPP), which predicts that international trade eventually leads exchange
rates to adjust until a typical basket of consumer goods and services in Canada costs the same as in
other countries.
The 6 points
rate on JetBlue
purchases is virtually unmatchable from its competitors, as most
other cards top out at around 3 points.
Major Canadian banks plan to increase their fees or have already hiked up their ATM, debit, and
purchase fees and charges
on other transactions to make up for profit losses due to falling interest
rates.
Some pay a flat
rate on all
purchases, while
others shell out higher rewards in certain categories, such as gas or groceries.
Most parents, with the best of intentions, go online and read reviews about gates and
purchase products based
on how
others have
rated the product.
59 % of respondents use social media to «vent» about a customer care experience 72 % of respondents research companies» customer care online prior to
purchasing at least sometimes 84 % of respondents consider the quality of customer care at least sometimes in their decision to do business with a company 74 % choose companies / brands based
on others» customer care experiences shared online 81 % believe that blogs, online
rating systems and discussion forums can give consumers a greater voice regarding customer careless than 33 % believe that businesses take customers» opinions seriously
As for the real money
purchase side of things, players will be able to buy an in - game currency that can be spent
on a variety of boosts that will increase the drop
rate for a variety of currencies and provide
other bonuses.
The Condemned (Lionsgate, April 27) Starring: Stone Cold Steve Austin, Vinnie Jones Director: Scott Wiper
Rating: NR The Pitch: Joe Conrad (Austin), a death row inmate in a Central American prison, has his freedom
purchased by a television producer, who then drops Conrad
on a remote island where he is forced to fight nine
other killers to the death.
Note: Feel free to visit my shop and
other resources and please
rate and feedback
on any
purchases, thank you.
The Coupe, however, must be
purchased in its most expensive Touring trim to get that top IIHS
rating, as Honda Sensing isn't even an option
on the
other four Civic Coupe trims.
Interest
rates (APR) and financing terms are based
on, among
other things, your credit and the age, model and
purchase price of the vehicle.
0.99 %
purchase financing (2.25 % APR) offered
on approved credit by TD Auto Finance Services, Scotiabank ® or RBC Royal Bank for 72 months
on eligible 2018 Chevrolet models: 2018 Malibu LT..
Other trims may have effective
rates higher than 0.99 %.
If you are one of my readers who has
purchased any of the
other books in the series
on Amazon, feel free to
rate and review the individual book or the whole series.
Sun explained that while Amazon and Goodreads primarily deliver book recommendations based
on «collaborative filtering» — namely, a user's
purchasing or
rating and reviewing history as well as those of
other users — Bookish doesn't have that user or
purchase data yet.
These points are worth approximately $ 0.01, resulting in a 5 % rewards
rate (1 %
on all
other purchases).
It features a fantastic 3.75 % rewards
rate for travel, advertising, internet and phone services, and shipping for the first $ 150,000 in combined
purchases, plus 1.25 %
on all
other spending.
It comes with a 2.1 % rewards
rate on dining and travel
purchases, and 1.05 %
on all
other purchases.
The card offers standard cash back
rates of 5 %
on quarterly categorical
purchases and 1 %
on all
other purchases.
APR
on purchases will be a variable
rate, currently 16.49 % to 25.49 %, based
on your creditworthiness and
other factors.
The rewards
rate on the VentureOne ® card ranges from 1.25 %
on travel expenses to as low as 0.625 %
on other purchases.
Beyond having a generous rewards
rate on restaurant, grocery store and JetBlue
purchases, as a cardmembers you get to enjoy a slew of
other features.
For Parents, Family and Friends: CHOOSE ANY OF THESE SERVICES - Visa ® Debit Card - Free checking, cash - back rewards, 1000 free ATMs, free Mobile Banking - Visa ® Credit Card - Free balance transfers, low
rates, cash - back rewards - Auto Loans - Low
rates on purchase or refinances - Home Equity Lines of Credit - Low
rates for home improvements, tuition, weddings or
other special purposes.
The 5 % rewards
rate it provides
on in - store
purchases will be unmatched by most
other offers out there.
Independent of this, the amount a student borrows may impact
other aspects of life — the ability to rent an apartment, to be offered a job at a bank, the
rate of a car loan — but the most closely felt impact is
on day - to - day bills and
purchases.
The low, promotional interest
rates offered by many dealer finance companies and
other lenders can lead to tremendous savings
on your next vehicle
purchase.
Your mortgage
rate depends
on many factors like the economy, your credit scores, the kind of property you're
purchasing, and
others.
Some cards offer a flat
rate for all types of
purchases,
other cards have a tiered reward
rate that might pay 5 % for gas but only 1 %
on everything else.
The card also gives you 2 points per $ 1 spent
on all
other purchases, but due to the low redemption
rate, it is not the best option for earning points
on non-hotel
purchases.
Some
purchase highly
rated bonds that may pay the fund a lower interest
rate but are considered less risky, while
others focus
on lower - quality, higher - yield bonds.